A Safety and Efficacy Study of a Topical Gel for the Treatment of Mild to Moderate Psoriasis
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to assess the tolerability and efficacy of a 0.10% or
0.05% PTH (1-34) parathyroid hormone peptide gel in the treatment of mild to moderate plaque
psoriasis in comparison to treatment with the placebo gel alone.